| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 04/19/2006 | CN1760194A Method for synthesizing 3-(5'-substitution-2-benzoxazole group)-7-diethyl amino group H-1-benzopyrans-2-ketone |
| 04/19/2006 | CN1252056C Method for chemical synthesis of N-[1 (S)-carbethoxy-3-hydro cinnamyl]-L-ulamine -N- carboxylic anhydride |
| 04/19/2006 | CN1252055C Biphenyl carboxamides compounds |
| 04/19/2006 | CN1252047C Benzene sulfonic derivative |
| 04/18/2006 | US7030241 Mesylates of piperazine derivatives and process for their preparation |
| 04/18/2006 | US7030148 Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them |
| 04/18/2006 | US7030143 Heterocyclic compounds |
| 04/18/2006 | US7030116 Compounds and compositions as cathepsin inhibitors |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/13/2006 | WO2006038606A1 Biaryl derivative |
| 04/13/2006 | WO2006038100A1 Oxazolidinone derivatives as antimicrobials |
| 04/13/2006 | WO2006037775A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 04/13/2006 | WO2006037480A1 Hexafluoroisopropanol substituted ether derivatives |
| 04/13/2006 | WO2005087752A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/13/2006 | US20060079696 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses |
| 04/13/2006 | US20060079694 Use of ionic salt catalyst based on phosphonium or quaternary ammonium cation and perfluoroalkylcarboxylate anion such as 3,3,3-trifluoropropanoic acid in the trimerization of isocyanates |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079528 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 04/13/2006 | CA2791783A1 Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel |
| 04/12/2006 | EP1645552A1 Double-spiro organic compounds and electroluminescent devices |
| 04/12/2006 | EP1644320A1 Indane derivates as muscarinic receptor agonists |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 04/12/2006 | EP1302466B1 Benzoxazole compound, process for producing the same, and herbicide |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP1003736B1 Substituted 4-benzoyl-pyrazoles |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759106A Process for the recovery of oxazole |
| 04/12/2006 | CN1759092A Synthesis of 2-chloromethyl-6-methylbenzoic ester |
| 04/12/2006 | CN1758907A Amino acid phenoxy ethers |
| 04/12/2006 | CN1250735C Method for production of non-proteinogen L-amino acid by fermentation |
| 04/12/2006 | CN1250627C UV absorbent for thermoplastic polymer and producing process thereof |
| 04/12/2006 | CN1250539C Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound |
| 04/12/2006 | CN1250532C Process for preparation of oxo-oxazoline or alloamino acid derivatives |
| 04/11/2006 | US7026515 Optically active amine derivatives and preparation process therefor |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026346 Anticancer agents |
| 04/11/2006 | US7026339 Inhibitors of HCV NS5B polymerase |
| 04/05/2006 | EP1641765A1 Aryl-heteroaromatic products, compositions containing same and use thereof |
| 04/05/2006 | EP1641453A2 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 04/05/2006 | EP1641452A1 Heterocyclic compounds useful to treat hcv |
| 04/05/2006 | CN1756748A 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 04/04/2006 | US7022723 Heterocyclic compounds |
| 04/04/2006 | CA2294624C Cationic monobenzene nitrophenylenediamines, their use in dying keratin fibres, dyeing compositions containing them and dyeing processes |
| 04/04/2006 | CA2179284C Substituted unsymmetrical cyanine dyes with selected permeability |
| 03/30/2006 | WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/30/2006 | WO2006016724A3 Liquid-crystalline compounds, compositions and thin films |
| 03/30/2006 | WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/30/2006 | US20060069282 Process for producing aromatic nitrile compound |
| 03/30/2006 | US20060069137 Novel process for ezetimibe intermediate |
| 03/30/2006 | DE102004044555A1 New modification of 2-indenylbutyric acid derivative, useful for treating e.g. diabetes and obesity, thermodynamically stable at room temperature |
| 03/30/2006 | CA2580725A1 Novel heterocyclic nf-kb inhibitors |
| 03/30/2006 | CA2580265A1 Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof |
| 03/30/2006 | CA2580238A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/29/2006 | EP1482934B1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases |
| 03/29/2006 | EP1303270B1 Method for treating cryptorchidism |
| 03/29/2006 | EP0979823B1 Novel amide compounds and drugs containing the same |
| 03/29/2006 | CN1753887A Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753881A 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 03/29/2006 | CN1753880A Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753879A (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 03/29/2006 | CN1753875A Growth promotion method |
| 03/29/2006 | CN1753855A Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives |
| 03/29/2006 | CN1753671A 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1247574C Isoindolin-1-one glucokinase activators |
| 03/28/2006 | US7019020 2-benzoxazolyl benzene derivatives and their use as UV screening agents |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer |
| 03/28/2006 | US7018978 Novel heterocyclic pro- fragrances, preferably oxazolidines, tertahydro-1,3-oxazines, thiazolidines, or tetrahydro-1,3-thiazines, more preferably oxazolidines, or tertahydro-1,3-oxazines, most preferably oxazolidines, which |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/23/2006 | WO2006030753A1 Therapeutic agent for keratoconjunctiva disorder |
| 03/23/2006 | WO2006030211A2 Acyclic sulphonamides |
| 03/23/2006 | WO2004087057A3 Methods for inhibition of angiogenesis |
| 03/23/2006 | US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
| 03/23/2006 | US20060063935 (4S)-3-((E)-2-butenoyl-4-benzyl-2-oxazolidinone;antocarcinogenic agent; controlling progression of cancer through metastasis in animal suffering from a colon, lung, or breast cancer; synergistic mixture with other chemotherapeutic agent or radiation |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | DE102004039509A1 Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl-cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments |
| 03/23/2006 | CA2579490A1 Therapeutic agent for keratoconjunctiva disorder |
| 03/22/2006 | EP1637525A1 Benzoxazole compound, process for producing the same, and herbicides |
| 03/22/2006 | EP1637138A2 Use of thiazolidinediones to prevent or delay onset of NIDDM |
| 03/22/2006 | EP1636198A1 Aniline derivatives |
| 03/22/2006 | EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 03/22/2006 | EP1635824A2 5-membered heterocycle-based p-38 inhibitors |
| 03/22/2006 | EP1328509B1 Methods of producing oxazolidinone compounds |
| 03/22/2006 | EP1315697B1 Herbicidal benzoyl cyclohexane dione |
| 03/22/2006 | EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy |
| 03/22/2006 | CN1751037A Sulfonamide derivatives as PPAR modulators |
| 03/22/2006 | CN1749256A Novel oxazolidone derivative, its preparing method and use |
| 03/22/2006 | CN1246287C Binaphthol derivative and method for producing same |
| 03/21/2006 | US7015331 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine. |
| 03/21/2006 | US7015208 carbocyclic alcohols such as 5-Chloro-2-methylsulfonylindan-1-ol and isomers, used as anorexigenic agents; side effect reduction; nontoxic |
| 03/21/2006 | CA2238986C Compounds with isocyanate groups and masked groups reactive in relation to isocyanates |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/16/2006 | US20060058289 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/16/2006 | US20060057644 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |